Primary Job Title Founder Primary Organization GenSight Biologics
Gender Male
Serge Picaud is director of research at the Vision Institute in Paris. Over the last 15 years, he has developed many cellular and animal models of different retinal diseases for assessing the efficacy of neuroprotection or other therapeutic strategies. He thus developed the culture of post-mortem human retinal tissue, which provides the means to
test AAV vectors efficacy on human retinal neurones.
He has also characterized many animal models using a phenotyping platform inspired from the clinical trial center. He was a founder and advisor of the biotech company Fovea, which was bought by Sanofi-Aventis to become its ophthalmological division.
